gabapentin has been researched along with Encephalopathy, Toxic in 8 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The most common adverse reactions (incidence ≥ 20%) with single-agent use are fatigue, nausea, and anorexia." | 5.39 | Pemetrexed-induced cellulitis: a rare toxicity in non-small cell lung cancer treatment. ( Katsenos, S; Panagou, C; Psara, A, 2013) |
| "This postmarketing surveillance study of lamotrigine (LTG) was performed to provide complementary data to large-scale Prescription-Event Monitoring study with a retrospective case records survey in five tertiary referral epilepsy centres in the United Kingdom." | 3.71 | Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom. ( Mawer, GE; Sander, JW; Wong, IC, 2001) |
| "Asterixis has been reported as a side effect of toxic and metabolic abnormalities." | 2.49 | Asterixis related to gabapentin intake: a case report and review. ( Wahba, M; Waln, O, 2013) |
| " It still remains unclear how much these drugs are safe during pregnancy." | 1.51 | The neurotoxic effects of prenatal gabapentin and oxcarbazepine exposure on newborn rats. ( Ayas, B; Ercument Beyhun, N; Erisgin, Z; Nyengaard, JR; Terzi, Y, 2019) |
| " The most common adverse reactions (incidence ≥ 20%) with single-agent use are fatigue, nausea, and anorexia." | 1.39 | Pemetrexed-induced cellulitis: a rare toxicity in non-small cell lung cancer treatment. ( Katsenos, S; Panagou, C; Psara, A, 2013) |
| " Its normal plasma half-life is 2 - 3 hours; dosage modifications are obligatory in renal insufficiency." | 1.35 | Drug-induced encephalopathy secondary to non renal dosing of common medications in Two dialysis patients. ( Iloanya, PC; Nye, D; Onuigbo, MA, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Selvy, M | 1 |
| Pereira, B | 1 |
| Kerckhove, N | 1 |
| Busserolles, J | 1 |
| Farsi, F | 1 |
| Guastella, V | 1 |
| Merle, P | 1 |
| Pezet, D | 1 |
| Balayssac, D | 1 |
| Erisgin, Z | 1 |
| Ayas, B | 1 |
| Nyengaard, JR | 1 |
| Ercument Beyhun, N | 1 |
| Terzi, Y | 1 |
| Wahba, M | 1 |
| Waln, O | 1 |
| Beauvais, K | 1 |
| Disson-Dautriche, A | 1 |
| Jacquin, A | 1 |
| Antoniol, C | 1 |
| Martin, ML | 1 |
| Onuigbo, MA | 1 |
| Nye, D | 1 |
| Iloanya, PC | 1 |
| Katsenos, S | 1 |
| Psara, A | 1 |
| Panagou, C | 1 |
| Alao, AO | 1 |
| Dewan, MJ | 1 |
| Wong, IC | 1 |
| Mawer, GE | 1 |
| Sander, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation by Oncologists of Strategies for the Prevention and Treatment of Chemotherapy-induced Peripheral Neuropathies: Observational and Cross-sectional Study[NCT03854864] | 216 participants (Actual) | Observational | 2019-01-14 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for gabapentin and Encephalopathy, Toxic
| Article | Year |
|---|---|
Asterixis related to gabapentin intake: a case report and review.
Topics: Aged; Amines; Cyclohexanecarboxylic Acids; Dyskinesias; Gabapentin; gamma-Aminobutyric Acid; Humans; | 2013 |
7 other studies available for gabapentin and Encephalopathy, Toxic
| Article | Year |
|---|---|
Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.
Topics: Adult; Amitriptyline; Antineoplastic Agents; Calcium; Cross-Sectional Studies; Duloxetine Hydrochlor | 2021 |
The neurotoxic effects of prenatal gabapentin and oxcarbazepine exposure on newborn rats.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Brain; Dopaminergic Neurons; Female; Gabapen | 2019 |
Gabapentin-induced encephalopathy.
Topics: Aged, 80 and over; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Electroencephalography; Fem | 2015 |
Drug-induced encephalopathy secondary to non renal dosing of common medications in Two dialysis patients.
Topics: Acyclovir; Aged; Amines; Analgesics; Antiviral Agents; Cyclohexanecarboxylic Acids; Gabapentin; gamm | 2009 |
Pemetrexed-induced cellulitis: a rare toxicity in non-small cell lung cancer treatment.
Topics: Adrenal Cortex Hormones; Aged; Amines; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Ca | 2013 |
Evaluating the tolerability of the newer mood stabilizers.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Central Nervous System Diseases; Cyclohexanecar | 2001 |
Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom.
Topics: Acetates; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Amines; Anticonvulsants; | 2001 |